Joachim, Von Pawel: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Rittmeyer, Achim, Barlesi, Fabrice, Waterkamp, Daniel, Park, Keunchil, Ciardiello, Fortunato, von Pawel, Joachim, Gadgeel, Shirish M, Hida, Toyoaki, Kowalski, Dariusz M, Dols, Manuel Cobo, Cortinovis,

Journal:

Year:

2017

Language:

english

File:

PDF, 1.32 MB

english, 2017

2

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

Nick Thatcher, Alex Chang, Purvish Parikh, José Rodrigues Pereira, Tudor Ciuleanu, Joachim von Pawel, Sumitra Thongprasert, Eng Huat Tan, Kristine Pemberton, Venice Archer, Kevin Carroll

Journal:

Year:

2005

Language:

english

File:

PDF, 158 KB

english, 2005

3

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

Reck, Martin, Kaiser, Rolf, Mellemgaard, Anders, Douillard, Jean-Yves, Orlov, Sergey, Krzakowski, Maciej, von Pawel, Joachim, Gottfried, Maya, Bondarenko, Igor, Liao, Meilin, Gann, Claudia-Nanette, Ba

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 382 KB

english, 2014

4

Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

von Pawel, Joachim, Harvey, Jimmie H., Spigel, David R., Dediu, Mircea, Reck, Martin, Cebotaru, Cristina L., Humphreys, Robin C., Gribbin, Matthew J., Fox, Norma Lynn, Camidge, D. Ross

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 569 KB

english, 2014

5

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study

Paz-Ares, Luis, Mezger, Jörg, Ciuleanu, Tudor E, Fischer, Jürgen R, von Pawel, Joachim, Provencio, Mariano, Kazarnowicz, Andrzej, Losonczy, György, de Castro, Gilberto, Szczesna, Aleksandra, Crino, Lu

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 312 KB

english, 2015

6

Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial

Hanna, Nasser H., Kaiser, Rolf, Sullivan, Richard N., Aren, Osvaldo Rudy, Ahn, Myung-Ju, Tiangco, Beatrice, Voccia, Isabelle, Pawel, Joachim von, Kovcin, Vladimir, Agulnik, Jason, Gaschler-Markefski,

Journal:

Year:

2016

Language:

english

File:

PDF, 667 KB

english, 2016

7

Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study

Gandara, David R., von Pawel, Joachim, Mazieres, Julien, Sullivan, Richard, Helland, Åslaug, Han, Ji-Youn, Ponce Aix, Santiago, Rittmeyer, Achim, Barlesi, Fabrice, Kubo, Toshio, Park, Keunchil, Goldsc

Journal:

Journal of Thoracic Oncology

Year:

2018

Language:

english

File:

PDF, 1.84 MB

english, 2018

8

Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma

Carl-Martin Kirsch, Joachim von Pawel, Irene Grau, Klaus Tatsch

Journal:

European Journal of Nuclear Medicine and Molecular Imaging

Year:

1994

Language:

english

File:

PDF, 2.30 MB

english, 1994

9

Circulating Nucleosomes in Serum

STEFAN HOLDENRIEDER, PETRA STIEBER, HEINZ BODENMÜLLER, MARTIN BUSCH, JOACHIM VON PAWEL, ANDREAS SCHALHORN, DOROTHEA NAGEL, DIETRICH SEIDEL

Journal:

Annals of the New York Academy of Sciences

Year:

2001

Language:

english

File:

PDF, 1.42 MB

english, 2001

10

Early and Specific Prediction of the Therapeutic Efficacy in Non–Small Cell Lung Cancer Patients by Nucleosomal DNA and Cytokeratin-19 Fragments

STEFAN HOLDENRIEDER, PETRA STIEBER, JOACHIM VON PAWEL, HANNELORE RAITH, DOROTHEA NAGEL, KNUT FELDMANN, DIETRICH SEIDEL

Journal:

Annals of the New York Academy of Sciences

Year:

2006

Language:

english

File:

PDF, 245 KB

english, 2006

11

Clinical Relevance of Circulating Nucleosomes in Cancer

Stefan Holdenrieder, Dorothea Nagel, Andreas Schalhorn, Volker Heinemann, Ralf Wilkowski, Joachim Von Pawel, Hannelore Raith, Knut Feldmann, Andreas E. Kremer, Susanne Müller, Sandra Geiger, Gerhard F

Journal:

Annals of the New York Academy of Sciences

Year:

2008

Language:

english

File:

PDF, 235 KB

english, 2008

12

Plasma growth hormone (GH)-releasing hormone levels in patients with lung carcinoma

Jochen Schopohl, Marco Lose, Chris Frey, Gernot Wolfram, Rudolf Huber, Willibald Permanetter, Joachim von Pawel, O. Albrecht Müller, Klaus von Werder

Journal:

Clinical Endocrinology

Year:

1991

Language:

english

File:

PDF, 480 KB

english, 1991

13

Pemetrexed in the treatment of malignant mesothelioma: Results from an expanded access program in Germany

Martin Reck, Rolf A. Stahel, Joachim von Pawel, Meinolf Karthaus, Soenke Korfee, Monika Serke, Wolfgang H.-W. Schuette, Corinna Eschbach, Thomas H. Fink, Monika I. Leschinger, Christian Manegold

Journal:

Respiratory Medicine

Year:

2010

Language:

english

File:

PDF, 214 KB

english, 2010

14

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Robert Pirker, Jose R Pereira, Aleksandra Szczesna, Joachim von Pawel, Maciej Krzakowski, Rodryg Ramlau, Ihor Vynnychenko, Keunchil Park, Chih-Teng Yu, Valentyn Ganul, Jae-Kyung Roh, Emilio Bajetta, K

Journal:

Year:

2009

Language:

english

File:

PDF, 201 KB

english, 2009

15

First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study

Ulrich Gatzemeier, Joachim von Pawel, Ihor Vynnychenko, Petr Zatloukal, Filippo de Marinis, Wilfried EE Eberhardt, Luis Paz-Ares, Karl-Maria Schumacher, Thomas Goddemeier, Kenneth J O'Byrne, Robert Pi

Journal:

The Lancet Oncology

Year:

2011

Language:

english

File:

PDF, 220 KB

english, 2011

16

Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study

Kenneth J O'Byrne, Ulrich Gatzemeier, Igor Bondarenko, Carlos Barrios, Corinna Eschbach, Uwe M Martens, Yevhen Hotko, Cornelius Kortsik, Luis Paz-Ares, Jose R Pereira, Joachim von Pawel, Rodryg Ramlau

Journal:

The Lancet Oncology

Year:

2011

Language:

english

File:

PDF, 1.59 MB

english, 2011

17

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

Robert Pirker, Jose R Pereira, Joachim von Pawel, Maciej Krzakowski, Rodryg Ramlau, Keunchil Park, Filippo de Marinis, Wilfried EE Eberhardt, Luis Paz-Ares, Stephan Störkel, Karl-Maria Schumacher, Anj

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 872 KB

english, 2012

18

Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer

Christian Manegold, Johan Vansteenkiste, Felipe Cardenal, Wolfgang Schuette, Penella J. Woll, Ernst Ulsperger, Anne Kerber, Josef Eckmayr, Joachim von Pawel

Journal:

Investigational New Drugs

Year:

2013

Language:

english

File:

PDF, 250 KB

english, 2013

19

Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide—A phase II study

Reck, Martin, Jagos, Urzula, Grunwald, Franziska, Kaukel, Eckhard, Koschel, Gabriele, von Pawel, Joachim, Hessler, Sybill, Gatzemeier, Ulrich

Journal:

Year:

2003

Language:

english

File:

PDF, 121 KB

english, 2003

20

PL-5 A phase III study of pemetrexed vs. docetaxel in patients with advanced non-small-cell lung cancer (NSCLC) who were previously treated with chemotherapy

Shepherd, Frances A., Pereira, Jose R., Von Pawel, Joachim, Gatzemeier, Ulrich, Yao Tsao, Thomas Chang, Hanna, Nasser, Rosell, Rafael, Paoletti, Paolo, Paul, Sofia, Bunn, Paul A., Einhorn, Lawrence

Journal:

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

21

The role of topotecan in treating small cell lung cancer: second-line treatment

von Pawel, Joachim

Journal:

Year:

2003

Language:

english

File:

PDF, 661 KB

english, 2003

22

O-59 Quality of life with single agent oral topotecan vs intravenous topotecan in patients with chemosensitive small cell lung cancer (SCLC). An international phase III study

Graila, Richard J., Eckardt, John, von Pawel, Joachim, Grotzinger, Kelly M., Ross, Graham A.

Journal:

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

23

P-202 Phase II trial of tirapazamine in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer (NSCLC)

Reck, Martin, von Pawel, Joachim, Nimmermann, Christa, Groth, Gesine, Gatzemeier, Ulrich

Journal:

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

24

P-436 ProGRP in serum enables diagnosis of small cell lung cancer

von Pawel, Joachim, Raith, Hannelore, Holdenrieder, Stefan, Feldmann, Knut, Stieber, Petra

Journal:

Year:

2003

Language:

english

File:

PDF, 184 KB

english, 2003

25

P-422 Prognostic factors in patients with advanced lung cancer

Holdenrieder, Stefan, Stieber, Petra, von Pawel, Joachim, Faderi, Bernhard, Wagner, Horst, Markus, Andreas, Raith, Hannelore, Nagel, Dorothea, Feldmann, Knut, Seidel, Dietrich

Journal:

Year:

2003

Language:

english

File:

PDF, 181 KB

english, 2003

26

P-421 Early prediction of the response to chemotherapy in patients with lung cancer by the course of apoptotic markers in serum

Holdenrieder, Stefan, Stieber, Petra, von Pawel, Joachim, Dankelmann, Elke, Kordes, Barbara, Siakavara, Maria, Raith, Hannelore, Nagel, Dorothea, Feldmann, Knut, Seidel, Dietrich

Journal:

Year:

2003

Language:

english

File:

PDF, 181 KB

english, 2003

27

P-569 The relationship between treatment-free interval (TFI) and outcomes to therapy in patients with relapsed Small Cell Lung Cancer (SCLC): A review of 631 patients treated with IV topotecan in 6 studies

von Pawel, Joachim, Ardizzoni, Andrea, Thatcher, Nicholas, Crofts, Theresa, Wissel, Paul, Dane, Graham, Ross, Graham

Journal:

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

28

Rationale and Design of MARQUEE: A Phase III, Randomized, Double-Blind Study of Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Patients With Locally Advanced or Metastatic, Nonsquamous, Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Silvia Novello, Joan H. Schiller, Vera Hirsh, Lecia V. Sequist, Jean-Charles Soria, Joachim von Pawel, Brian Schwartz, Reinhard Von Roemeling, Alan B. Sandler

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 332 KB

english, 2012

29

Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: Quality of life and 6-years’-follow-up results from a randomised phase III trial

Reck, Martin, von Pawel, Joachim, Macha, Hans-Nicholas, Kaukel, Eckhard, Deppermann, Karl-Matthias, Bonnet, Reiner, Ulm, Kurt, Hessler, Sybill, Gatzemeier, Ulrich

Journal:

Year:

2006

Language:

english

File:

PDF, 341 KB

english, 2006

30

Effect of chemotherapy for advanced non-small cell lung cancer on patients’ quality of life

Belani, Chandra P., Pereira, Jose R., von Pawel, Joachim, Pluzanska, Anna, Gorbounova, Vera, Kaukel, Eckhard, Mattson, Karin V., Ramlau, Rodryg, Szczesna, Aleksandra, Fidias, Panos, Millward, Michael,

Journal:

Year:

2006

Language:

english

File:

PDF, 362 KB

english, 2006

31

Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer

Holdenrieder, Stefan, von Pawel, Joachim, Dankelmann, Elke, Duell, Thomas, Faderl, Bernhard, Markus, Andreas, Siakavara, Maria, Wagner, Horst, Feldmann, Knut, Hoffmann, Harald, Raith, Hannelore, Nagel

Journal:

Year:

2009

Language:

english

File:

PDF, 414 KB

english, 2009

32

Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m2 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

McKeage, Mark J., Reck, Martin, Jameson, Michael B., Rosenthal, Mark A., Gibbs, David, Mainwaring, Paul N., Freitag, Lutz, Sullivan, Richard, Von Pawel, Joachim

Journal:

Year:

2009

Language:

english

File:

PDF, 250 KB

english, 2009

33

An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases

Sandler, Alan, Hirsh, Vera, Reck, Martin, von Pawel, Joachim, Akerley, Wallace, Johnson, David H.

Journal:

Year:

2012

Language:

english

File:

PDF, 243 KB

english, 2012

34

The emerging role of MET/HGF inhibitors in oncology

Scagliotti, Giorgio V., Novello, Silvia, von Pawel, Joachim

Journal:

Cancer Treatment Reviews

Year:

2013

Language:

english

File:

PDF, 289 KB

english, 2013

35

A randomised phase II study of pemetrexed versus pemetrexed+erlotinib as second-line treatment for locally advanced or metastatic non-squamous non-small cell lung cancer

Dittrich, Christian, Papai-Szekely, Zsolt, Vinolas, Nuria, Sederholm, Christer, Hartmann, Joerg T., Behringer, Dirk, Kazeem, Gbenga, Desaiah, Durisala, Leschinger, Monika I., von Pawel, Joachim

Journal:

European Journal of Cancer

Year:

2014

Language:

english

File:

PDF, 517 KB

english, 2014

36

Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancer

Heigener, David F., von Pawel, Joachim, Eschbach, Corinna, Brune, Andreas, Schmittel, Alexander, Schmelter, Thomas, Reck, Martin, Fischer, Jürgen R.

Journal:

Year:

2013

Language:

english

File:

PDF, 316 KB

english, 2013

37

DISRUPT: A randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane–platinum regimen as first-line therapy for metastatic non-small cell lung cancer

von Pawel, Joachim, Gorbounova, Vera, Reck, Martin, Kowalski, Dariusz M., Allard, Aurore, Chadjaa, Mustapha, Rey, Augustin, Bennouna, Jaafar, Grossi, Francesco

Journal:

Year:

2014

Language:

english

File:

PDF, 946 KB

english, 2014

38

Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial

Ramalingam, Suresh S, Jänne, Pasi A, Mok, Tony, O'Byrne, Kenneth, Boyer, Michael J, Von Pawel, Joachim, Pluzanski, Adam, Shtivelband, Mikhail, Docampo, Lara Iglesias, Bennouna, Jaafar, Zhang, Hui, Lia

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 523 KB

english, 2014

39

A Phase II Randomized Study of Cisplatin-Pemetrexed plus either Enzastaurin or Placebo in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer

Vansteenkiste, Johan, Ramlau, Rodryg, von Pawel, Joachim, San Antonio, Belen, Eschbach, Corinna, Szczesna, Aleksandra, Kennedy, Liam, Visseren-Grul, Carla, Chouaki, Nadia, Reck, Martin

Journal:

Year:

2012

Language:

english

File:

PDF, 102 KB

english, 2012

40

Psychometric validation of the Patient Symptom Assessment in Lung Cancer instrument for small cell lung cancer

Chen, Lei, Antras, Lucia, Sheng Duh, Mei, Levy, Natalie, Neary, Maureen, O'Brien, Mary E. R., von Pawel, Joachim

Journal:

Current Medical Research and Opinion

Year:

2007

Language:

english

File:

PDF, 501 KB

english, 2007

41

Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer

Novello, Silvia, Kaiser, Rolf, Mellemgaard, Anders, Douillard, Jean-Yves, Orlov, Sergey, Krzakowski, Maciej, von Pawel, Joachim, Gottfried, Maya, Bondarenko, Igor, Liao, Meilin, Barrueco, José, Gaschl

Journal:

European Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 771 KB

english, 2015

42

Diagnostische Bedeutung zirkulierender DNA- Fragmente in der Onkologie. Diagnostic importance of circulating DNA fragments in oncology

Holdenrieder, Stefan, Pawel, Joachim von, Schalhorn, Andreas, Stieber, Petra

Journal:

Laboratoriums Medizin

Year:

2005

File:

PDF, 198 KB

2005

43

Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo in First-Line Non–Small-Cell Lung Cancer

Jänne, Pasi A., Paz-Ares, Luis, Oh, Yun, Eschbach, Corinna, Hirsh, Vera, Enas, Nathan, Brail, Leslie, von Pawel, Joachim

Journal:

Journal of Thoracic Oncology

Year:

2014

Language:

english

File:

PDF, 329 KB

english, 2014

44

Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel

Reck, Martin, Mellemgaard, Anders, von Pawel, Joachim, Gottfried, Maya, Bondarenko, Igor, Cheng, Ying, Zarogoulidis, Kostas, Luft, Alexander, Bennouna, Jaafar, Barrueco, José, Aboshady, Hesham, Hocke,

Journal:

Year:

2015

Language:

english

File:

PDF, 4.06 MB

english, 2015

45

Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) im Stadium IV

Deppermann, Karl-Matthias, Huber, Rudolf M., Laack, Eckart, Reck, Martin, Serke, Monika, Pawel, Joachim von

Journal:

Year:

2006

Language:

german

File:

PDF, 182 KB

german, 2006

46

Erlotinib in Patients with Previously Irradiated, Recurrent Brain Metastases from Non-Small Cell Lung Cancer: Two Case Reports

von Pawel, Joachim, Wagner, Horst, Duell, Thomas, Poellinger, Barbara

Journal:

Year:

2008

Language:

english

File:

PDF, 154 KB

english, 2008

47

An Open-Label, Multicenter, Randomized, Phase II Study of Pazopanib in Combination with Pemetrexed in First-Line Treatment of Patients with Advanced-Stage Non–Small-Cell Lung Cancer

Scagliotti, Giorgio V., Felip, Enriqueta, Besse, Benjamin, von Pawel, Joachim, Mellemgaard, Anders, Reck, Martin, Bosquee, Lionel, Chouaid, Christos, Lianes-Barragán, Pilar, Paul, Elaine M., Ruiz-Soto

Journal:

Journal of Thoracic Oncology

Year:

2013

Language:

english

File:

PDF, 145 KB

english, 2013

48

Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer

Schiller, Joan H., von Pawel, Joachim, Schütt, Philipp, Ansari, Rafat H., Thomas, Michael, Saleh, Mansoor, McCroskey, Robert D., Pfeifer, Wolfgang, Marsland, Thomas A., Kloecker, Goetz H., Sebastian,

Journal:

Journal of Thoracic Oncology

Year:

2010

Language:

english

File:

PDF, 566 KB

english, 2010

49

Safety and Resource Utilization by Non-small Cell Lung Cancer Histology: Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaïve Patients with Advanced Non-small Cell Lung Cancer

Novello, Silvia, Pimentel, Francisco Luis, Douillard, Jean-Yves, O'Brien, Mary, von Pawel, Joachim, Eckardt, John, Liepa, Astra M., Simms, Lorinda, Visseren-Grul, Carla, Paz-Ares, Luis

Journal:

Journal of Thoracic Oncology

Year:

2010

Language:

english

File:

PDF, 444 KB

english, 2010

50

Gefitinib (Iressa, ZD1839): a novel targeted approach for the treatment of solid tumors

Von Pawel}, Joachim

Journal:

Bulletin du Cancer

Year:

2004

Language:

english

File:

PDF, 124 KB

english, 2004